Gallstone dissolution in vitro by bile acids, heparin, and quanternary amines.
D000473:Alkanes / Q000627:therapeutic use; D001647:Bile Acids and Salts / Q000008:administration & dosage / Q000627:therapeutic use*; D002594:Cetylpyridinium / Q000008:administration & dosage / Q000627:therapeutic use; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D002769:Cholelithiasis / Q000188:drug therapy* / Q000378:metabolism; D002784:Cholesterol / Q000032:analysis; D002793:Cholic Acids / Q000008:administration & dosage / Q000627:therapeutic use; D002849:Chromatography, Gas; D003840:Deoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use*; D006584:Hexamethonium Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D007440:Intubation; D011726:Pyridinium Compounds / Q000627:therapeutic use*; D012965:Sodium Chloride / Q000008:administration & dosage / Q000627:therapeutic use; D013501:Surface-Active Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000473:Alkanes; D001647:Bile Acids and Salts; D002793:Cholic Acids; D006584:Hexamethonium Compounds; D011726:Pyridinium Compounds; D013501:Surface-Active Agents; D003840:Deoxycholic Acid; D002635:Chenodeoxycholic Acid; D012965:Sodium Chloride; D006493:Heparin; D002784:Cholesterol; D002594:Cetylpyridinium